Corporate Member Update: Oncopeptides- Melphalan Flufenamide (PEPAXTO®) Update
Corporate Member Update: Oncopeptides- Melphalan Flufenamide (PEPAXTO®) Update
Melphalan Flufenamide (PEPAXTO®)
September, 2021
Permanent J-Code Assigned for Pepaxto® (melphalan flufenamide)
Effective, October 1, 2021
J9247
Injection, melphalan flufenamide, 1 mg1
To read the full press release, click here!
